Invention Grant
- Patent Title: Truncated VWF
-
Application No.: US16610701Application Date: 2018-05-04
-
Publication No.: US11339204B2Publication Date: 2022-05-24
- Inventor: Thomas McKinnon , Mike Laffan
- Applicant: Imperial College Innovations Ltd
- Applicant Address: GB London
- Assignee: Imperial College Innovations Ltd
- Current Assignee: Imperial College Innovations Ltd
- Current Assignee Address: GB London
- Agency: Meunier Carlin & Curfman LLC
- Priority: GB1707139 20170504
- International Application: PCT/GB2018/051212 WO 20180504
- International Announcement: WO2018/203086 WO 20181108
- Main IPC: C07K14/755
- IPC: C07K14/755 ; A61K38/095 ; A61P7/04 ; A61K31/196 ; A61K45/06
Abstract:
The present invention relates to novel truncated fragments of von Willebrand factor (VWF) and the use of such fragments and nucleic acids encoding such fragments in the treatment of von Willebrand disease (VWD) and haemophilia.
Public/Granted literature
- US20200157186A1 TRUNCATED VWF Public/Granted day:2020-05-21
Information query
